OBJECTIVE: To determine optimal methods of identifying enrollees with possible depression for additional depression screening in the context of a care management program for chronically ill Medicare recipients. STUDY DESIGN: Observational analysis of telephone and mail survey and claims data collected for the Medicare Health Support (MHS) program. METHODS: This study examines data from 14,902 participants with diabetes mellitus and/or congestive heart failure in the MHS program administered by Green Ribbon Health, LLC. Depression screening was performed by administering a 2-item screen (the Patient Health Questionnaire 2 [PHQ-2]) by telephone or by mail. Additional information about possible depression was drawn from International Classification of Diseases, Ninth Revision (ICD-9) depression diagnoses on claims and from self-reported use of antidepressant medications. We evaluated positive depression screens using the PHQ-2 administered via telephone versus mail, examined variations in screener-positive findings by care manager, and compared rates of positive screens with antidepressant use and with claims diagnoses of depression. RESULTS: Almost 14% of participants received an ICD-9 diagnosis of depression during the year before program enrollment; 7.1% reported taking antidepressants, and 5.1% screened positive for depression on the PHQ-2. We found substantial variation in positive depression screens by care manager that could not be explained by case mix, prior depression diagnoses, or current depression treatment. After adjusting for demographic and clinical differences, the PHQ-2-positive screen rates were 6.5% by telephone and 14.1% by mail (P <.001). CONCLUSION: A multipronged effort composed of mail screening (using the PHQ-2), self-reported antidepressant use, and claims diagnoses of depression may capture the greatest number of enrollees with possible depression.
OBJECTIVE: To determine optimal methods of identifying enrollees with possible depression for additional depression screening in the context of a care management program for chronically ill Medicare recipients. STUDY DESIGN: Observational analysis of telephone and mail survey and claims data collected for the Medicare Health Support (MHS) program. METHODS: This study examines data from 14,902 participants with diabetes mellitus and/or congestive heart failure in the MHS program administered by Green Ribbon Health, LLC. Depression screening was performed by administering a 2-item screen (the Patient Health Questionnaire 2 [PHQ-2]) by telephone or by mail. Additional information about possible depression was drawn from International Classification of Diseases, Ninth Revision (ICD-9) depression diagnoses on claims and from self-reported use of antidepressant medications. We evaluated positive depression screens using the PHQ-2 administered via telephone versus mail, examined variations in screener-positive findings by care manager, and compared rates of positive screens with antidepressant use and with claims diagnoses of depression. RESULTS: Almost 14% of participants received an ICD-9 diagnosis of depression during the year before program enrollment; 7.1% reported taking antidepressants, and 5.1% screened positive for depression on the PHQ-2. We found substantial variation in positive depression screens by care manager that could not be explained by case mix, prior depression diagnoses, or current depression treatment. After adjusting for demographic and clinical differences, the PHQ-2-positive screen rates were 6.5% by telephone and 14.1% by mail (P <.001). CONCLUSION: A multipronged effort composed of mail screening (using the PHQ-2), self-reported antidepressant use, and claims diagnoses of depression may capture the greatest number of enrollees with possible depression.
Authors: Gregory E Simon; Wayne J Katon; Elizabeth H B Lin; Carolyn Rutter; Willard G Manning; Michael Von Korff; Paul Ciechanowski; Evette J Ludman; Bessie A Young Journal: Arch Gen Psychiatry Date: 2007-01
Authors: Wayne Katon; Jürgen Unützer; Ming-Yu Fan; John W Williams; Michael Schoenbaum; Elizabeth H B Lin; Enid M Hunkeler Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112
Authors: John W Williams; Michael Pignone; Gilbert Ramirez; Christina Perez Stellato Journal: Gen Hosp Psychiatry Date: 2002 Jul-Aug Impact factor: 3.238
Authors: Lea C Watson; Carmen L Lewis; Christine E Kistler; Halle R Amick; Malaz Boustani Journal: Int J Geriatr Psychiatry Date: 2004-03 Impact factor: 3.485
Authors: Na Shin; Felicia Hill-Briggs; Susan Langan; Jennifer L Payne; Constantine Lyketsos; Sherita Hill Golden Journal: J Diabetes Complications Date: 2017-02-12 Impact factor: 2.852
Authors: Sherita Hill Golden; Nina Shah; Mohammad Naqibuddin; Jennifer L Payne; Felicia Hill-Briggs; Gary S Wand; Nae-Yuh Wang; Susan Langan; Constantine Lyketsos Journal: Psychosomatics Date: 2016-08-15 Impact factor: 2.386
Authors: Margaret Maxwell; Fiona Harris; Carina Hibberd; Eddie Donaghy; Rebekah Pratt; Chris Williams; Jill Morrison; Jennifer Gibb; Philip Watson; Chris Burton Journal: BMC Fam Pract Date: 2013-04-04 Impact factor: 2.497